fluorodeoxyglucose f18 has been researched along with Digestive System Neoplasms in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 14 (48.28) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 3 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| Buck, AK; Hartrampf, PE; Higuchi, T; Kosmala, A; Lindner, T; Michalski, K; Schirbel, A; Schlötelburg, W; Serfling, SE; Weich, A; Werner, RA | 1 |
| Akin, EA; Osman, M; Qazi, ZN; Zeman, RK | 1 |
| Cao, J; Chen, Y; He, J; Liu, H; Peng, D; Wang, Y | 1 |
| Hendel, HW; Jensen, BV; Nielsen, D; Skougaard, K | 1 |
| Bergestuen, DS; Khan, MS; Kim, MK; Oberg, K; Rinke, A; Salazar, R; Thirlwell, C; Toumpanakis, C | 1 |
| Camp, A; Delpassand, ES; Erion, JL; Espenan, GD; Hamiditabar, M; Krenning, EP; Kvols, LK; Mojtahedi, A; O'Dorisio, TM; Samarghandi, A; Simon, J; Wolfangel, R; Wolin, EM; Zamanian, S | 1 |
| Alberini, JL; Cacheux, W; Gauthé, M; Jouve, JL; Lièvre, A; Michel, P; Mitry, E; Richard-Molard, M | 1 |
| Ji, YH; Lv, L; Tian, Y; Wang, QS; Wang, SB; Wu, HB; Zhou, WL | 1 |
| Gao, ZR; Jia, Q; Lan, XL; Wei, H; Wu, ZJ; Zhang, YX | 1 |
| Chua, SC; O'Connor, SR; Rozalli, FI | 1 |
| Avigdor, A; Davidson, T; Goitein, O; Goshen, E; Zwas, ST | 1 |
| Feeley, CM; Gerbaudo, VH; Shyn, PB; Silverman, SG; Tatli, S; Tuncali, K | 1 |
| Kwee, SA; Lan, BY; Wong, LL | 1 |
| Han, A; Hu, M; Wang, X; Xue, J; Zheng, J | 1 |
| Schillaci, O | 1 |
| Abramson, S; Arora, VC; Fleming, S; LaQuaglia, MP; Magnan, H; Price, AP; Sohn, MJ | 1 |
| Cabrera Villegas, A; Gámez Cenzano, C; García Velloso, MJ | 1 |
| Bourguet, P | 1 |
| Chin, BB; Wahl, RL | 1 |
| Anzai, Y; Coltrera, M; Eary, J; Krohn, K; Rajendran, J; Schwartz, DL; Yueh, B | 1 |
| Akeboshi, M; Hataji, O; Nakatsuka, A; Taguchi, O; Takao, M; Takeda, K; Yamakado, K | 1 |
| Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Talbot, JN | 1 |
| Bourguet, P; Metges, JP; Mitry, E; Monteil, J; Planchamp, F; Tubiana-Mathieu, N | 1 |
| Klippenstein, DL; Lamonica, DM | 1 |
| Andre, T; Grahek, D; Grange, JD; Gutman, F; Houry, S; Huchet, V; Kerrou, K; Montravers, F; Poupon, R; Rosmorduc, O; Rougier, P; Ruszniewski, P; Talbot, JN; Touboul, E | 1 |
| Borson-Chazot, F; Chayvialle, JA; Janier, M; Kryza, D; Le Bars, D; Nejjari, M; Perek, N; Poncet, G; Roche, C; Scoazec, JY | 1 |
| Ido, T; Kanamaru, R; Maeda, S; Oikawa, H; Takahashi, H; Takahashi, T; Tezuka, F; Wakui, A; Watanabe, T; Yoshioka, T | 1 |
| Artus, JC; Herry, JY; Lumbroso, J; Maublant, J; Muratet, JP; Talbot, JN; Vuillez, JP | 1 |
| Brenner, W; Czech, N; Henze, E; Kampen, WU | 1 |
14 review(s) available for fluorodeoxyglucose f18 and Digestive System Neoplasms
| Article | Year |
|---|---|
Clinical impact of FDG PET/CT in alimentary tract malignancies: an updated review.
Topics: Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
FAPI PET/CT research progress in digestive system tumours.
Topics: Digestive System Neoplasms; Endopeptidases; Fluorodeoxyglucose F18; Humans; Membrane Proteins; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Magnetic Resonance Imaging; Molecular Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radionuclide Imaging; Receptors, Somatostatin; Sensitivity and Specificity; Stomach Neoplasms; Surveys and Questionnaires; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers.
Topics: Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neuroendocrine Tumors; Patient Care Planning; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Imaging features of primary extranodal lymphomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Bone Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Contrast Media; Diagnosis, Differential; Diagnostic Imaging; Digestive System Neoplasms; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed; Urogenital Neoplasms | 2009 |
Positron emission tomography in hepatobiliary and pancreatic malignancies: a review.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2012 |
Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity.
Topics: Breast Neoplasms; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity | 2012 |
[Positron emission tomography (PET) in clinical oncology [Part III]].
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in digestive system neoplasms].
Topics: Colorectal Neoplasms; Digestive System Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2003 |
18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies.
Topics: Adult; Colorectal Neoplasms; Digestive System Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2003 |
[Positron emission tomography (PET) in gastrointestinal cancer].
Topics: Contraindications; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
[Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)].
Topics: Anus Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Digestive System Neoplasms; Endocrine Gland Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Intestine, Large; Liver Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2007 |
[PET and digestive cancers].
Topics: Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2008 |
[Diagnostic value of positron emission tomography (PET) in clinical oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Diagnosis, Differential; Digestive System Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Urogenital Neoplasms | 2000 |
3 trial(s) available for fluorodeoxyglucose f18 and Digestive System Neoplasms
| Article | Year |
|---|---|
Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cetuximab; Colorectal Neoplasms; Denmark; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Irinotecan; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors: the first US phase 2 experience.
Topics: Adult; Aged; Digestive System Neoplasms; Disease Progression; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Predictive Value of Tests; Quality of Life; Radiopharmaceuticals; Receptors, Somatostatin; Texas; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.
Topics: Aged; Carcinoma; Catheter Ablation; Contrast Media; Digestive System Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluoroscopy; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Iohexol; Leiomyosarcoma; Lung Neoplasms; Male; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms | 2004 |
12 other study(ies) available for fluorodeoxyglucose f18 and Digestive System Neoplasms
| Article | Year |
|---|---|
Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Colonic Neoplasms; Digestive System Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
18F-FDG PET/CT in differentiating malignant from benign origins of obstructive jaundice.
Topics: Aged; Bile Ducts; Carcinoma; Cholecystitis; Choledocholithiasis; Constriction, Pathologic; Digestive System Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Jaundice, Obstructive; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
18F- FDG-PET/CT for the diagnosis of tumor thrombosis.
Topics: Adult; Aged; Carcinoma; Cohort Studies; Diagnosis, Differential; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphoma; Male; Middle Aged; Neoplastic Cells, Circulating; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Thromboembolism; Tomography, X-Ray Computed | 2009 |
PET/CT-guided percutaneous biopsy of abdominal masses: initial experience.
Topics: Adult; Aged; Biopsy, Needle; Boston; Digestive System Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiography, Interventional; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Urologic Neoplasms | 2012 |
Characteristic imaging features of desmoplastic small round cell tumour.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Desmoplastic Small Round Cell Tumor; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Young Adult | 2013 |
Staging of head and neck squamous cell cancer with extended-field FDG-PET.
Topics: Carcinoma, Squamous Cell; Digestive System Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Neoplasms, Multiple Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Preoperative imaging for metastasectomy.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma; Colorectal Neoplasms; Contrast Media; Diagnostic Imaging; Digestive System Neoplasms; Enteroendocrine Cells; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2007 |
In vitro and in vivo studies with [(18)F]fluorocholine on digestive tumoral cell lines and in an animal model of metastasized endocrine tumor.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Choline; Digestive System Neoplasms; Endocrine Gland Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Mice; Neoplasm Metastasis; Radionuclide Imaging | 2008 |
Accumulation of 2-deoxy-2[18F]fluoro-D-glucose in human cancers heterotransplanted in nude mice: comparison between histology and glycolytic status.
Topics: Animals; Contrast Media; Deoxyglucose; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Tissue Distribution; Tumor Cells, Cultured | 1994 |
[Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
Topics: Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Lung Neoplasms; Lymphoma; Male; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |